+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Milk Oligosaccharides (HMO) - Global Strategic Business Report

  • PDF Icon

    Report

  • 99 Pages
  • September 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303048
The global market for Human Milk Oligosaccharides (HMO) is estimated at US$236.1 Million in 2023 and is projected to reach US$565.6 Million by 2030, growing at a CAGR of 13.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Infant Formula Application segment, which is expected to reach US$444 Million by 2030 with a CAGR of a 12.9%. The Functional Food & Beverage Application segment is also set to grow at 17.1% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $61.2 Million in 2023, and China, forecasted to grow at an impressive 17.2% CAGR to reach $137.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Human Milk Oligosaccharides (HMO) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Human Milk Oligosaccharides (HMO) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Human Milk Oligosaccharides (HMO) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Basf SE, Dextra Laboratories Limited, DuPont Nutrition & Health, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 53 Featured):

  • Basf SE
  • Dextra Laboratories Limited
  • DuPont Nutrition & Health
  • Elicityl SA
  • Glycom A/S
  • Glycosyn LLC
  • Inbiose
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • Nestlé Health Science
  • ZuChem, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Human Milk Oligosaccharides (HMO) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Functional Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Functional Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Functional Food & Beverage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Food Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Food Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Food Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Human Milk Oligosaccharides (HMO) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 17: USA Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 18: USA Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 19: USA 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
CANADA
  • Table 20: Canada Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 21: Canada Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 22: Canada 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
JAPAN
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 23: Japan Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 24: Japan Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 25: Japan 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
CHINA
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 26: China Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 27: China Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 28: China 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
EUROPE
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 29: Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 31: Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 32: Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 33: Europe Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 34: Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
FRANCE
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 35: France Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 36: France Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 37: France 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
GERMANY
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 38: Germany Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 39: Germany Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 40: Germany 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
ITALY
  • Table 41: Italy Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 42: Italy Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 43: Italy 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 44: UK Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 45: UK Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 46: UK 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
SPAIN
  • Table 47: Spain Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 48: Spain Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 49: Spain 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
  • Table 50: Russia Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 51: Russia Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 52: Russia 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 53: Rest of Europe Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 54: Rest of Europe Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 55: Rest of Europe 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Human Milk Oligosaccharides (HMO) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 59: Asia-Pacific Recent Past, Current & Future Analysis for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • Table 60: Asia-Pacific Historic Review for Human Milk Oligosaccharides (HMO) by Application - Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • Table 61: Asia-Pacific 16-Year Perspective for Human Milk Oligosaccharides (HMO) by Application - Percentage Breakdown of Value Sales for Infant Formula, Functional Food & Beverage, Food Supplements and Other Applications for the Years 2014, 2024 & 2030
AUSTRALIA
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Human Milk Oligosaccharides (HMO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Basf SE
  • Dextra Laboratories Limited
  • DuPont Nutrition & Health
  • Elicityl SA
  • Glycom A/S
  • Glycosyn LLC
  • Inbiose
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • Nestlé Health Science
  • ZuChem, Inc.

Table Information